Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.42
BATS BZX Real-Time Price
As of 3:48pm ET
 +0.11 / +2.07%
Today’s Change
3.61
Today|||52-Week Range
11.15
-11.58%
Year-to-Date

Today’s Trading

Previous close5.31
Today’s open5.43
Day’s range5.21 - 5.48
Volume69,919
Average volume (3 months)931,979
Market cap$371.4M
Dividend yield--
Data as of 3:48pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+137.50%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...+1.92+10.39%
OMEDOncoMed Pharmaceutic...0.000.00%
ADMSAdamas Pharmaceutica...+0.07+0.41%
SGNTSagent Pharmaceutica...+0.21+1.80%
Data as of 3:47pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers

Search for Jobs